Congestive heart failure in elderly patients: Controlled study of delapril (cas 110508-92-4) versus captopril

Add time:08/21/2019    Source:sciencedirect.com

In this controlled trial, 30 elderly patients with congestive heart failure, New York Heart Association (NYHA) classes II and III, were randomly assigned to treatment with captopril 25 mg three times daily or delapril (cas 110508-92-4) 15 mg twice daily. At the end of an 8-week treatment period, clinical symptoms of heart failure were significantly relieved by both drugs, with a consistent and statistically significant improvement in patients' quality of life evaluated using a symptoms/activity scale (p <0.001). None of the patients was judged NYHA class III at the end of the trial and 40% were assigned to class I (p <0.01). There was a relevant, but not statistically significant, increase in exercise duration in both treatment groups (10% captopril group, 14% delapril group), but the number of patients discontinuing the exercise test for dyspnea was 50% less in the delapril group. Neither drug had evident effects on echocardiographic left ventricular parameters. Two patients treated with captopril and 3 with delapril complained of mild-to-moderate adverse reactions. The safety of both drugs was confirmed by laboratory tests.

We also recommend Trading Suppliers and Manufacturers of delapril (cas 110508-92-4). Pls Click Website Link as below: cas 110508-92-4 suppliers

Prev:delapril (cas 110508-92-4) slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits
Next:Safety and efficacy study of delapril (cas 110508-92-4) versus enalapril in patients with congestive heart failure)